PEDIATRICS Vol. 13 No. 6 June 1954, pp. 503-510
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HSIA, D. Y.-Y.
Right arrow Articles by GELLIS, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HSIA, D. Y.-Y.
Right arrow Articles by GELLIS, S. S.

STUDIES ON ERYTHROBLASTOSIS DUE TO ABO INCOMPATIBILITY

DAVID YI-YUNG HSIA M.D.1 and SYDNEY S. GELLIS M.D.1

1 The Department of Pediatrics, Beth Israel Hospital, the Boston Lying-In Hospital, the Children's Medical Center, and the Department of Pediatrics, Harvard Medical School, Boston.

Detailed clinical and laboratory data have been presented on 21 infants with erythroblastosis due to ABO incompatibility. A careful survey in one newborn service over a six-month period showed that there were 11 cases of erythroblastosis due to ABO incompatibility as compared to 7 cases of erythroblastosis due to Rh incompatibility, suggesting that the disease occurs with greater frequency than has been hitherto reported.

No one test is available which can in every case be absolutely diagnostic of the disease. The criteria useful in suggesting the diagnosis are listed. Practically, the presence of a major blood group incompatibility between infant and mother with a negative Coombs' test, clinical jaundice in the first 24 hours, and a serum bilirubin level of more than 10 mg./100 cc. at 24 hours or less is sufficient to make the diagnosis in the absence of manifest infection.

The same criteria for treatment as applied to Rh erythroblastosis should be applied to erythroblastosis due to ABO incompatibility in the light of our present knowledge.

Submitted on June 15, 1953




This article has been cited by other articles:


Home page
 PediatricsHome page
J. F. Watchko
Vigintiphobia Revisited
Pediatrics, June 1, 2005; 115(6): 1747 - 1753.
[Abstract] [Full Text] [PDF]